Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Relapsed or Refractory Multiple Myeloma
.
Show all posts
Showing posts with label
Relapsed or Refractory Multiple Myeloma
.
Show all posts
Sunday, January 5, 2020
FDA Approves Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
›
In continuation of my update on Selinexor Karyopharm Therapeutics Inc. an oncology-focused pharmaceutical company, announced that ...
›
Home
View web version
